$2.39
0.020.84%
At Close: -
$2.57
0.187.53%
After Hours: 7:32 PM EDT
15 minutes delayed
MDxHealth
MDXHNASDAQ
MDxHealth (NASDAQ:MDXH) Stock, Analyst Ratings, Price Targets, Predictions
MDxHealth SA has a consensus price target of $9.67, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, BTIG, and Piper Sandler on March 7, 2024, March 7, 2024, and November 9, 2023. With an average price target of $7 between Piper Sandler, BTIG, and Piper Sandler, there's an implied 192.89% upside for MDxHealth SA from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
BTIG
TD Cowen
William Blair
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for MDxHealth
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/07/2024 | Buy Now | 192.89% | Piper Sandler | Jason Bednar | $6 → $7 | Maintains | Overweight | Get Alert |
| 03/07/2024 | Buy Now | 234.73% | BTIG | Mark Massaro | $7 → $8 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | 151.05% | Piper Sandler | Jason Bednar | $10 → $6 | Maintains | Overweight | Get Alert |
| 05/31/2023 | Buy Now | 192.89% | TD Cowen | Dan Brennan | → $7 | Initiates | → Outperform | Get Alert |
| 05/16/2023 | Buy Now | 192.89% | BTIG | Mark Massaro | $8 → $7 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | 234.73% | BTIG | Mark Massaro | $8 → $8 | Maintains | Buy | Get Alert |
| 03/24/2023 | Buy Now | — | William Blair | Andrew Brackmann | — | Initiates | → Outperform | Get Alert |
| 03/09/2023 | Buy Now | 234.73% | BTIG | Mark Massaro | $12 → $8 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 318.41% | Piper Sandler | Jason Bednar | $15 → $10 | Maintains | Overweight | Get Alert |
| 11/09/2022 | Buy Now | 402.09% | BTIG | Mark Massaro | → $12 | Maintains | Buy | Get Alert |
| 10/31/2022 | Buy Now | 485.77% | BTIG | Mark Massaro | → $14 | Maintains | Buy | Get Alert |
| 08/26/2022 | Buy Now | 527.62% | BTIG | Mark Massaro | $13 → $15 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | 653.14% | Oppenheimer | Francois Brisebois | → $18 | Assumes | → Outperform | Get Alert |
| 11/29/2021 | Buy Now | 653.14% | Oppenheimer | Kevin DeGeeter | — | Initiates | → Outperform | Get Alert |
| 11/29/2021 | Buy Now | 527.62% | BTIG | Mark Massaro | — | Initiates | → Buy | Get Alert |
| 11/29/2021 | Buy Now | 527.62% | Piper Sandler | Jason Bednar | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for MDxHealth (MDXH) stock?
The latest price target for MDxHealth (NASDAQ:MDXH) was reported by Piper Sandler on March 7, 2024. The analyst firm set a price target for $7.00 expecting MDXH to rise to within 12 months (a possible 172.37% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MDxHealth (MDXH)?
The latest analyst rating for MDxHealth (NASDAQ:MDXH) was provided by Piper Sandler, and MDxHealth maintained their overweight rating.
When was the last upgrade for MDxHealth (MDXH)?
There is no last upgrade for MDxHealth
When was the last downgrade for MDxHealth (MDXH)?
There is no last downgrade for MDxHealth.
When is the next analyst rating going to be posted or updated for MDxHealth (MDXH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MDxHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MDxHealth was filed on March 7, 2024 so you should expect the next rating to be made available sometime around March 7, 2025.
Is the Analyst Rating MDxHealth (MDXH) correct?
While ratings are subjective and will change, the latest MDxHealth (MDXH) rating was a maintained with a price target of $6.00 to $7.00. The current price MDxHealth (MDXH) is trading at is $2.57, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.